(Q53381394)

13 May 2018

title

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. (English)

1 reference

13 May 2018

0 references

1 reference

L Volin

12

0 references

Francesco Dazzi

object named as

F Dazzi

5

0 references

Yves Chalandon

object named as

Y Chalandon

1

0 references

Per Ljungman

7

object named as

P Ljungman

1 reference

13 May 2018

J R Passweg

2

1 reference

13 May 2018

C Schmid

3

1 reference

13 May 2018

E Olavarria

4

1 reference

13 May 2018

M P Simula

6

1 reference

13 May 2018

A Schattenberg

8

1 reference

13 May 2018

T de Witte

9

1 reference

13 May 2018

S Lenhoff

10

1 reference

13 May 2018

P Jacobs

11

1 reference

13 May 2018

S Iacobelli

13

1 reference

13 May 2018

J Finke

14

1 reference

13 May 2018

D Niederwieser

15

1 reference

13 May 2018

C Guglielmi

16

1 reference

13 May 2018

Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation

17

1 reference

13 May 2018

language of work or name

English

0 references

publication date

27 July 2009

1 reference

13 May 2018

Bone Marrow Transplantation

published in

1 reference

13 May 2018

volume

45

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

558-564

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2009.177

exact match

0 references

cites work

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Adoptive immunotherapy in canine chimeras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.177

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.177

1 reference

13 May 2018

Dimensions Publication ID

0 references

1 reference

13 May 2018